68Ga-NOTA-RGD-GE11

N/A

Report date: 2025/12/29 17:43:10

NME

Base Information

Drug Name68Ga-NOTA-RGD-GE11

Drug Alias Name68Ga-NOTA-RGD-cys-6-Ahx-GE11NOTA-RGD-cys-6-Ahx-GE11-[68Ga]Gallium-68-NOTA-RGD-cys-6-Ahx-GE11

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionIntegrin modulatorsEpidermal growth factor receptor erbB1 modulators

TargetsIntegrinEpidermal growth factor receptor erbB1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Nuclear Energy Research, Taiwan

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Nuclear Energy Research, Taiwan

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A